Full List Of Stories
AstraZeneca, MSD prostate cancer drug gets China green light
AstraZeneca and MSD’s Lynparza prostate cancer drug has been granted conditional approval in China after a successful phase three trial, the companies said on Thursday.
Europe open: Shares open lower on renewed inflation worries, Delta cases
European shares fell in early trade on Wednesday as worries about rising inflation resurfaced and increase in Covid-19 Delta variant cases also dampened sentiment.
Dixons Carphone returns to profit, resumes dividend as online sales soar
Dixons Carphone reinstated its dividend as it swung back to profit on the back of a massive boost in online electrical goods sales during Covid lockdowns.
Serco sees H1 profits up more than 50% on Covid contracts
Government contractor Serco said it expected interim underlying trading profits to rise more than 50% driven by its work running the UK’s Covid track and trace system.
Europe midday: Shares hold gains as IWG bid talk cools
European shares maintained gains at midday on Tuesday, despite the rumoured bidder for IWG saying it was not planning to make an offer for the workspace provider.
Europe open: Shares rally as IWG bid rumours spur investors
European shares rallied at the opening on Tuesday as reports of a potential takeover for IWG boosted the market.
CD&R confirms higher £2.7bn offer for UDG Healthcare
US private equity firm Clayton, Dubilier & Rice on Tuesday confirmed its increased final £2. 7bn offer for Dublin-based UDG Healthcare.
Europe midday: Travel stocks fall as Germany pushes for EU-wide quarantine
European shares tumbled into the red across the board by midday Monday with travel stocks under pressure after Germany pushed the European Union to designate the UK a "country of concern" and introduce strict quarantine measures for British travellers.
Greggs sales recovery since May 10 'stronger than expected'
High Street bakery chain Greggs has reported a stronger than expected recovery in sales from the Covid pandemic since early May which could have a "materially positive" impact on annual earnings.
Europe open: Shares make muted start on Covid worries
European shares were flat at the opening on persistent inflation worries and a fall in travel stocks as governments battled to stymie the Delta variant of Covid-19.
NatWest sells Irish commercial loan book to AIB for €4.1bn
UK bank NatWest Group said it was selling most of its Irish commercial lending business to Allied Irish Banks as part of its exit from Ireland.
JD Sports buys Spain's Deporvillage for up to €140m
International sports retailer JD Sports Fashion it had bought 80% of Spanish cycling, running and outdoor equipment seller Deporvillage for up to €140. 4m.
Europe midday: Shares still flat as investors await US inflation data
European shares remained mixed at midday on Friday as investors awaited key US inflation data later in the day.
CD&R mulling improved 1,080p a share bid for UDG Healthcare
UDG Healthcare on Friday said US private equity firm Clayton Dubilier & Rice was considering lifting its bid after pressure from major shareholders, with the new offer valuing the Irish firm at £2. 76bn.
Europe open: Shares mixed despite US infrastructure bill optimism
European shares were mixed at the open on Friday despite US and Asian markets cheering a large US infrastructure spending bill.
Asia report: Shares rebound after US infrastructure deal agreed
Asian stocks rebounded on Friday on the back of momentum from Wall Street as a bipartisan $579bn US infrastructure deal was agreed.
Europe midday: Shares rally as German business sentiment soars
European shares rallied strongly by midday as investors focused on the pandemic recovery and looked beyond any threats to economic stimulus from rising inflation.
Asia report: Shares closed mixed in lacklustre trade
Asian shares were closed mixed on Thursday as investors looked for more clarity on US inflation ahead of official data on Friday.
Europe open: Shares open higher as investors look for direction
European shares opened higher on Thursday on as investors continued to look for positive signs from the Covid-19 pandemic recovery against a backdrop of what they hope is a temporary rise in inflation.
Bunzl sees rise in H1 revenue as recovery offset by fall in Covid orders
Distribution specialist Bunzl forecast a rise in first-half revenue as a recovery in its base business, including the food service and retail sectors, was largely offset by an anticipated fall in Covid-related orders.